The global fish skin disease market encompasses diseases affecting external skin layers of fish including fungi, bacteria and parasites. Major fish skin diseases include epitheliocystis, Lymphocystis disease, and skin ulcers. Epitheliocystis caused by Chlamydia bacteria is a highly prevalent bacterial infection affecting various freshwater and marine fish species globally. Meanwhile, Lymphocystis disease virus causes white cauliflower-like tumors or papillae on the skin and fins of fresh and saltwater fish species. Skin ulcers frequently occur as secondary infections following other diseases, injuries or environmental stressors. Fish skin disease diagnosis primarily depends on visual examination and microscopic evaluation of skin scrapings. Common treatment involves administration of antimicrobial drugs such as carbadox and oxytetracycline through feed or baths.
The global Fish Skin Disease Market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The global fish skin disease market is flourishing significantly due to the rising aquaculture production globally. Aquaculture is the world’s fastest growing food production system and fish skin disease outbreaks can be devastating for commercial fish farms with major economic losses. Hence, effective preventive measures and timely treatment of afflicted fish are crucial.
Market Dynamics:
According to Food and Agriculture Organization (FAO), global aquaculture production has increased from ~59 million tonnes in 1994 to ~110 million tonnes in 2016.China, India, Vietnam, Indonesia and Bangladesh are the top five aquaculture producers in the world. Increased fish farming activities exponentially elevate the risk of disease transmission and outbreaks, thereby fuelling demand for fish skin disease diagnosis and therapeutics. Availability of a wide range of antibiotics and prescription drugs for fish skin disease treatment by market players also propels the market growth. However, concerns regarding development of antibiotic resistance due to overuse of antimicrobials in aquaculture may hinder the market to a certain extent. Advanced research focusing on development of novel alternative therapeutics such as probiotics, prebiotics and phytochemicals for sustainable fish skin disease management can present lucrative opportunities for market players over the forecast period.
Segment Analysis
The fish skin disease market is segmented based on disease type, treatment type, end user, and geography. Based on disease type, the market is segmented into fish pox, bacterial and fungal infection, skin hemorrhage and open ulcers. Among these, fish pox is dominating the segment, accounting for over 35% of the market share. This is because fish pox causes ulcerative lesions on the fish skin and is highly contagious among aquatic species.
PEST Analysis
Political: Governments across various countries are supporting the aquaculture industry by providing subsidies and technology transfers. This is positively impacting the fish skin disease market.
Economic: Rising disposable income and growing demand for seafood are driving the growth of the aquaculture industry. This is increasing the risk of various infectious diseases among fish species and boosting demand for effective treatments.
Social: With growing health consciousness, people are preferring seafood over red meat due to associated health benefits. This is augmenting the consumption of fish and shrimp worldwide.
Technological: Companies are investing in R&D to develop novel drug formulations and advanced diagnostic techniques for timely detection and effective treatment of fish skin disease. Development of fish vaccines is another technological advancement aiding market growth.
Key Takeaways
The Global Fish Skin Disease Market Size is expected to witness high growth over the forecast period. The global fish skin disease market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030.
Regional analysis related content comprises
The Asia Pacific region is expected to maintain its dominance in the global fish skin disease market during the forecast period. This can be attributed to the large aquaculture industry in countries such as China, India, Vietnam, Indonesia, and Thailand. Presence of tropical climatic conditions that are more conducive for various infectious pathogens increasing the risk of disease outbreaks. Furthermore, rising seafood exports from the region is fueling market growth.
Key players related content comprises
Key players operating in the fish skin disease market are Glaxo Smith Kline PLC., Isarna Therapeutics GmbH, Aptose Biosciences Inc., Regulus Therapeutics Inc., and Rexahn Pharmaceuticals Inc. Glaxo Smith Kline is one of the prominent players offering anti-fungal and antibacterial drugs to treat fungal and bacterial infections in fish.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it